Latest NmVac4-A/C/Y/W-135 Stories
This study is a Phase 3, Randomized, Placebo-Controlled, Double-Blind Trial to Assess the Safety, Tolerability and Immunogenicity of a new Meningococcal Vaccine When Given in Healthy Subjects Age 11 to 26. (PRWEB) December 17, 2012 **Avail Clinical Research is now enrolling for a Meningitis Vaccine Clinical Trial near Orlando Florida. To get started, visit Avail Clinical Research or call us directly at (386) 310-1334. Neisseria meningitidis is a leading cause of bacterial meningitis in...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.